Corrigan Catherine 4
4 · EXPONENT INC · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
Exponent (EXPO) CEO Catherine Corrigan Exercises Options, Sells Shares
What Happened
- Catherine Corrigan, President & CEO and Director of Exponent (EXPO), exercised stock options on 2026-05-15 to acquire 5,606 shares (2,380 shares at $29.05 and 3,226 shares at $25.41), paying about $151,096 in exercise price.
- On the same day she disposed of shares: two open-market sales totaling 4,194 shares at $54.06 per share for combined proceeds of $226,726. The filing also records derivative disposals of 5,606 shares (N/A price), consistent with shares surrendered in connection with the exercise. Footnote indicates the stock sale was to cover the option exercise price and taxes.
Key Details
- Transaction date: 2026-05-15 (filed same day; timely).
- Options exercised: 2,380 @ $29.05 (cost $69,139) and 3,226 @ $25.41 (cost $81,957) — total 5,606 shares, ~$151,096 paid.
- Open-market sales: 1,827 @ $54.06 (proceeds $98,767) and 2,367 @ $54.06 (proceeds $127,959) — total 4,194 shares, ~$226,726 proceeds.
- Derivative disposals: 3,226 and 2,380 shares shown as disposed (N/A price) — corresponds to exercised shares surrendered/withheld.
- Footnotes: F1 — sales were to cover option exercise price and taxes; F2 — the option vests in four equal annual installments; F3 — not applicable.
- Shares owned after transaction: not specified in the provided excerpt — see the full Form 4 for total beneficial ownership.
Context
- This was an option exercise followed by share dispositions to cover the exercise cost and tax withholding (commonly called a cashless exercise/sell-to-cover). Exercises are purchases of stock via option conversion; subsequent sales to cover taxes are routine and do not necessarily indicate a change in insider sentiment.
Insider Transaction Report
Form 4
EXPONENT INCEXPO
Corrigan Catherine
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2026-05-15$29.05/sh+2,380$69,139→ 107,598 total - Sale
Common Stock
[F1]2026-05-15$54.06/sh−1,827$98,767→ 105,771 total - Exercise/Conversion
Common Stock
2026-05-15$25.41/sh+3,226$81,957→ 107,585 total - Sale
Common Stock
[F1]2026-05-15$54.06/sh−2,367$127,959→ 105,218 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F3][F2]2026-05-15−3,226→ 3,225 totalExercise: $25.41Exp: 2026-07-29→ Common Stock (3,226 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F3][F2]2026-05-15−2,380→ 7,138 totalExercise: $29.05Exp: 2027-02-16→ Common Stock (2,380 underlying)
Footnotes (3)
- [F1]Stock sale was to cover the option exercise price and taxes.
- [F2]The stock option becomes exercisable in four equal annual installments.
- [F3]Not applicable.
Signature
By: Wendy Whitehouse For: Catherine Corrigan|2026-05-15